mRNA Vaccines and Leukemia: New Research Raises Critical Metabolic Questions
Originally published: 2025-06-11
"Even subtle shifts in metabolism can have outsized impacts in the delicate ecosystem of the bone marrow—especially when leukemia is in play."
A Closer Look at the Unspoken Consequences
A new peer-reviewed study published in Current Molecular Medicine has unearthed quietly alarming findings that could reshape how we understand the effects of the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine—particularly in the context of leukemia and bone marrow health. Using sophisticated metabolomic profiling, researchers from Hacettepe University compared bone marrow samples from vaccinated leukemia patients, unvaccinated leukemia patients, and healthy controls. The results? Subtle but notable differences in key metabolic pathways—differences we cannot afford to ignore.
The Study at a Glance
The researchers used untargeted LC-QTOF-MS metabolomics to examine bone marrow samples from:
7 leukemia patients who had received the mRNA vaccine
2 leukemia patients who had not been vaccinated or infected
7 healthy, unvaccinated controls
The findings revealed that while the metabolic profiles of vaccinated and unvaccinated leukemia patients were broadly similar, several metabolites differed meaningfully, including:
↑ 5-Methoxyindoleacetate
↑ Tetrahydrofolic acid
↓ Phosphorylcholine
These aren't trivial changes. They touch central pathways in immunity, cellular proliferation, and leukemic progression.
“Vaccination may modulate the metabolic tone of the bone marrow”
Pathophysiological Red Flags
Far from being random fluctuations, the metabolite shifts suggest that vaccination may modulate the metabolic tone of the bone marrow—particularly concerning in individuals already battling or predisposed to hematologic malignancies.
Tryptophan Metabolism (↑ 5-Methoxyindoleacetate)
Tryptophan derivatives like 5-methoxyindoleacetate are intimately tied to immune suppression and tumor progression through the serotonin, kynurenine, and indole pathways. These can shape an immunosuppressive tumor microenvironment, disrupt T-cell regulation, and promote leukemic survival.
Folate Pathway (↑ Tetrahydrofolic Acid)
Tetrahydrofolic acid is central to purine and pyrimidine synthesis, the raw materials of DNA and RNA. Elevated THF may reflect increased metabolic stress or unregulated leukemic proliferation—potentially amplified by the immune and inflammatory cascade triggered by the vaccine.
Lipid Metabolism (↓ Phosphorylcholine)
Phosphorylcholine’s decline points to a disruption in membrane lipid turnover and cellular signaling. This could suggest a shift in how leukemic cells interface with their environment, or how immune cells mobilize within the marrow niche.
"These are not side effects. They are system effects—occurring in the metabolic heart of immunity and hematopoiesis."
A Warning for the Immunocompromised
The authors attempted to tread cautiously in their conclusions, stopping short of making causal claims. But the metabolic patterns speak volumes. Vaccinated leukemia patients consistently showed metabolic changes not seen in healthy controls, and some metabolites shifted in directions known to support immune evasion, oxidative stress tolerance, and drug resistance.
In a healthy person, this might not matter. In someone with leukemia, it might be the tipping point between remission and relapse.
The Silence is Deafening
Despite these findings, mainstream medical and media institutions continue to insist that the vaccine is “safe and effective”—full stop. There is little appetite to ask whether bone marrow metabolism in vulnerable patients should be part of that equation. Instead of rigorous investigation, we get the same worn disclaimers: “More research is needed,” “Sample sizes were small,” or “There’s no proven causality.”
But at what point do the patterns become impossible to dismiss?
"The question isn't whether mRNA vaccines work. The question is what else they do—and to whom."
Final Thoughts: A Call for Caution, Not Panic
This study doesn't prove that mRNA vaccines cause leukemia. But it does raise deep, biologically plausible concerns about how these vaccines interact with the metabolic landscape of the bone marrow. And in medicine, subtle changes can precede catastrophic shifts.
We must stop brushing these findings aside. If we truly care about protecting the immunocompromised, that protection must include metabolic and immunological integrity—not just antibody titers.
Call to Action:
If you're a clinician, researcher, or policymaker, the time for complacency is over. Start asking better questions. Demand deeper answers. And stop silencing the science when it doesn’t fit the narrative.
